Rodbard HW, Rosenstock J, Canani LH, Deerochanawong C, Gumprecht J, Lindberg S, et al
These medications improve blood sugar regulation regardless of diabetes status, offering valuable tools for metabolic health
No: Safe to take dose early Yes: Preferably wait for scheduled day, but one day early is acceptable if necessary Outcome: Take dose early and resume normal 7-day schedule from the new injection day
Learning Objectives Describe the differences between 503a and 503b compounding laws Define the benefits and limitations of current compounding legislation, considering their impact on the product availability and safety Explain why GLP-1Ras can legally be compounded Summarize safety concerns/alerts identified by the FDA regarding the use of compounded GLP-1ra products Evaluation All participants will have the opportunity to review the educational sessions and speakers and to identify future educational needs
But as more patients explore or discontinue these medications, functional and integrative medicine providers have a growing opportunity to offer complementary or alternative strategies that support similar metabolic pathwaysoften with fewer side effects